Related Experiment Video
Updated: Jan 30, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
MicroRNAs in peritoneal fibrosis: a systematic review
Katsunori Yanai1, Hiroki Ishii1, Akinori Aomatsu1,2
1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama 330-8503, Japan.
Abstract:
Peritoneal fibrosis is a crucial complication of long-term peritoneal dialysis (PD). Peritoneal fibrosis contributes to the development of peritoneal membrane failure, which leads to withdrawal from PD. No specific biomarkers or therapies have yet been established for peritoneal fibrosis. MicroRNAs (miRNAs) are small noncoding RNAs that can inhibit the translation of target messenger RNAs. Previous studies have shown that miRNAs play pivotal roles in the development of peritoneal fibrosis, indicating that they may represent potential biomarkers and therapeutic options for peritoneal fibrosis. Therefore, this systematic review focuses on miRNAs in peritoneal fibrosis, with regard to their potential as biomarkers, and miRNA modulation as a therapeutic option.
Insights
MicroRNAs (miRNAs) show promise as biomarkers and therapeutic targets for peritoneal fibrosis, a serious complication of long-term peritoneal dialysis (PD). This review explores their potential to improve PD patient outcomes.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Peritoneal fibrosis is a major complication of long-term peritoneal dialysis (PD), leading to membrane failure and PD withdrawal.
- Currently, no specific biomarkers or therapies exist for peritoneal fibrosis.
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression and are implicated in fibrotic diseases.
Purpose of the Study:
- To systematically review the role of miRNAs in the development of peritoneal fibrosis.
- To evaluate the potential of miRNAs as biomarkers for peritoneal fibrosis.
- To explore miRNA modulation as a therapeutic strategy for peritoneal fibrosis.
Main Methods:
- Systematic literature review of studies investigating miRNAs in peritoneal fibrosis.
- Analysis of miRNA expression patterns and their correlation with peritoneal fibrosis.
- Assessment of preclinical and clinical data on miRNA-based therapies for peritoneal fibrosis.
Main Results:
- Previous studies indicate that specific miRNAs are dysregulated in peritoneal fibrosis.
- These miRNAs show potential as diagnostic or prognostic biomarkers.
- Modulating miRNA activity presents a promising therapeutic avenue for preventing or reversing peritoneal fibrosis.
Conclusions:
- MicroRNAs play a significant role in the pathogenesis of peritoneal fibrosis.
- miRNAs represent viable candidates for novel biomarkers and therapeutic targets in PD patients.
- Further research is warranted to translate these findings into clinical practice.
Related Concept Videos
MicroRNAs
MicroRNAs
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

